Beyond PRP and Stem Cells: Clinical Applications of Amniotic Tissue Allografts in Veterinary Medicine
Regenerative medicine is expanding beyond PRP and stem-cell therapies. This session introduces amniotic tissue allografts as a tissue-derived regenerative modality and explains how regenerative therapies influence healing through paracrine signaling. Attendees will compare the signal-delivery characteristics of PRP, stem cells, and amniotic tissue, then review the biologic properties of canine amnion, including anti-inflammatory, anti-fibrotic, immunomodulatory, angiogenic, and extracellular-matrix-associated factors. Using AlphaFlo® as the clinical model, the presentation covers product characteristics, routes of administration, practical tissue-supporting considerations, and case examples involving wounds, tendon injury, ocular disease, joints, and neurologic conditions. The session is designed to give veterinarians a practical framework for understanding where amniotic tissue allografts may fit within regenerative medicine and how they can be incorporated into clinical decision-making.
- Explain how paracrine signaling contributes to tissue repair and regenerative medicine.
- Compare how PRP, stem cells, and amniotic tissue allografts deliver biologic signals.
- Identify key anti-inflammatory, immunomodulatory, anti-fibrotic, and pro-repair components associated with amniotic tissue.
- Recognize practical clinical applications, routes of administration, and case-selection considerations for canine amniotic tissue allografts.
